StockSelector.com
  Research, Select, & Monitor Friday, December 14, 2018 11:32:10 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Aclaris Therapeutics, Inc.$7.27($.38)(4.97%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Aclaris Therapeutics, Inc. has an overall rank of 6171 out of 7429 stocks based on 8 positive rankings and 6 negative rankings.

Positive Rankings
Oversold RSI
The 14 Day Relative-Strength Index for Aclaris Therapeutics is 23.4. An RSI below 30 indicates the stock is oversold. Among companies with a low RSI, Aclaris Therapeutics is ranked 131.
Debt-to-Equity
Aclaris Therapeutics rank is 138
Low vPut/Call
Aclaris Therapeutics has a low Put/Call ratio of 0.20 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Aclaris Therapeutics is ranked 347.
PEGValue
Aclaris Therapeutics has a PEG Value of $16.62. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 117.21% in the next year. Among companies with a PEG Value above the current stock price, Aclaris Therapeutics is ranked 446.
Oversold Stochastics
Aclaris Therapeutics rank is 885
Up EPS Surprise
Aclaris Therapeutics beat the consensus earnings estimate when it last reported quarterly earnings.
Low Put/Call
Aclaris Therapeutics has a low Put/Call ratio of 0.42 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Aclaris Therapeutics is ranked 1127.
Price-to-Book
Aclaris Therapeutics rank is 1313
Negative Rankings
Negative Net Margin
Aclaris Therapeutics rank is 149
Price-to-Sales
Aclaris Therapeutics rank is 204
90 Day Loss
Aclaris Therapeutics rank is 295
Negative ROA
Aclaris Therapeutics rank is 823
Negative ROE
Aclaris Therapeutics rank is 826
10 Day Loss
Aclaris Therapeutics rank is 938







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.